Multisystemic Production of Interleukin 10 Limits the Severity of Acute Pancreatitis in Mice

Overview

Journal Gut

Specialty Gastroenterology

Date 1998 Dec 24

PMID 9863488

Citations 34

Authors

J L Van Laethem

R Eskinazi

H Louis

F Rickaert

P Robberecht

J Deviere

Affiliations

Soon will be listed here.

Abstract

Background: Interleukin 10 (IL-10) decreases the severity of experimental acute pancreatitis. The role of endogenous IL-10 in modulating the course of pancreatitis is currently unknown.

Aims: To examine the systemic release of IL-10 and its messenger RNA production in the pancrease, liver, and lungs and analyse the effects of IL-10 neutralisation in caerulein induced acute pancreatitis in mice.

Methods: Acute necrotising pancreatitis was induced by intraperitoneal caerulein. Serum levels of IL-10 and tumour necrosis factor (TNF), and tissue IL-10 and TNF-alpha gene expression were assessed. After injecting control antibody or after blocking the activity of endogenous IL-10 by a specific monoclonal antibody, the severity of acute pancreatitis was assessed in terms of serum enzyme release, histological changes, and systemic and tissue TNF production.

Results: In control conditions, serum IL-10 levels increased and correlated with the course of pancreatitis, with a maximal value eight hours after induction. Both IL-10 and TNF-alpha messengers showed a similar course, and were identified in the pancreas, liver, and lungs. Neutralisation of endogenous IL-10 significantly increased the severity of pancreatitis and associated lung injury as well as serum TNF protein levels (+75%) and pancreatic, pulmonary, and hepatic TNF messenger expression (+33%, +29%, +43%, respectively).

Conclusions: In this non-lethal model, systemic release of IL-10 correlates with the course of acute pancreatitis. This anti-inflammatory response parallels the release of TNF and both cytokines are produced multisystemically. Endogenous IL-10 controls TNF-alpha production and plays a protective role in the local and systemic consequences of the disease.

Citing Articles

TRP14 is the rate-limiting enzyme for intracellular cystine reduction and regulates proteome cysteinylation.

Marti-Andres P, Finamor I, Torres-Cuevas I, Perez S, Rius-Perez S, Colino-Lage H EMBO J. 2024; 43(13):2789-2812.

PMID: 38811853 PMC: 11217419. DOI: 10.1038/s44318-024-00117-1.

Interleukins: pathophysiological role in acute pancreatitis.

Rafaqat S, Patoulias D, Behnoush A, Sharif S, Klisic A Arch Med Sci. 2024; 20(1):138-156.

PMID: 38414463 PMC: 10895951. DOI: 10.5114/aoms/178183.

Circulating Biomarkers Involved in the Development of and Progression to Chronic Pancreatitis-A Literature Review.

Poulsen V, Hadi A, Werge M, Karstensen J, Novovic S Biomolecules. 2024; 14(2).

PMID: 38397476 PMC: 10887223. DOI: 10.3390/biom14020239.

Effect of Synbiotics in Reducing the Systemic Inflammatory Response and Septic Complications in Moderately Severe and Severe Acute Pancreatitis: A Prospective Parallel-Arm Double-Blind Randomized Trial.

Rohith G, Sureshkumar S, Anandhi A, Kate V, Rajesh B, Abdulbasith K Dig Dis Sci. 2022; 68(3):969-977.

PMID: 35857241 DOI: 10.1007/s10620-022-07618-1.

Ketorolac and Predicted Severe Acute Pancreatitis: A Randomized, Controlled Clinical Trial.

Vahdat Shariatpanahi Z, Shahbazi S, Shahbazi E Clin Med Res. 2022; 20(2):74-80.

PMID: 34996820 PMC: 9242735. DOI: 10.3121/cmr.2021.1663.

References

Guice K, Oldham K, Caty M, Johnson K, Ward P . Neutrophil-dependent, oxygen-radical mediated lung injury associated with acute pancreatitis. Ann Surg. 1989; 210(6):740-7. PMC: 1357865. DOI: 10.1097/00000658-198912000-00008. View

Niederau C, Ferrell L, Grendell J . Caerulein-induced acute necrotizing pancreatitis in mice: protective effects of proglumide, benzotript, and secretin. Gastroenterology. 1985; 88(5 Pt 1):1192-204. DOI: 10.1016/s0016-5085(85)80079-2. View

de Waal Malefyt R, Abrams J, Bennett B, Figdor C, De Vries J . Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991; 174(5):1209-20. PMC: 2119001. DOI: 10.1084/jem.174.5.1209. View

Bogdan C, Vodovotz Y, Nathan C . Macrophage deactivation by interleukin 10. J Exp Med. 1991; 174(6):1549-55. PMC: 2119047. DOI: 10.1084/jem.174.6.1549. View

Jaeschke H, Farhood A, Smith C . Neutrophil-induced liver cell injury in endotoxin shock is a CD11b/CD18-dependent mechanism. Am J Physiol. 1991; 261(6 Pt 1):G1051-6. DOI: 10.1152/ajpgi.1991.261.6.G1051. View

Youker K, Smith C, Anderson D, Miller D, Michael L, Rossen R . Neutrophil adherence to isolated adult cardiac myocytes. Induction by cardiac lymph collected during ischemia and reperfusion. J Clin Invest. 1992; 89(2):602-9. PMC: 442893. DOI: 10.1172/JCI115626. View

Viedma J, Perez-Mateo M, Dominguez J, Carballo F . Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A. Gut. 1992; 33(9):1264-7. PMC: 1379499. DOI: 10.1136/gut.33.9.1264. View

Gerard C, Bruyns C, Marchant A, Abramowicz D, Vandenabeele P, Delvaux A . Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med. 1993; 177(2):547-50. PMC: 2190913. DOI: 10.1084/jem.177.2.547. View

Cassatella M, Meda L, Bonora S, Ceska M, Constantin G . Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by.... J Exp Med. 1993; 178(6):2207-11. PMC: 2191270. DOI: 10.1084/jem.178.6.2207. View

10.

Grewal H, Mohey el Din A, Gaber L, Kotb M, Gaber A . Amelioration of the physiologic and biochemical changes of acute pancreatitis using an anti-TNF-alpha polyclonal antibody. Am J Surg. 1994; 167(1):214-8; discussion 218-9. DOI: 10.1016/0002-9610(94)90076-0. View

11.

Willems F, Marchant A, Delville J, Gerard C, Delvaux A, Velu T . Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol. 1994; 24(4):1007-9. DOI: 10.1002/eji.1830240435. View

12.

Marchant A, Bruyns C, Vandenabeele P, Ducarme M, Gerard C, Delvaux A . Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol. 1994; 24(5):1167-71. DOI: 10.1002/eji.1830240524. View

13.

Le Moine O, Marchant A, Durand F, Ickx B, Pradier O, Belghiti J . Systemic release of interleukin-10 during orthotopic liver transplantation. Hepatology. 1994; 20(4 Pt 1):889-92. DOI: 10.1002/hep.1840200417. View

14.

Jungermann J, Lerch M, Weidenbach H, Lutz M, Kruger B, Adler G . Disassembly of rat pancreatic acinar cell cytoskeleton during supramaximal secretagogue stimulation. Am J Physiol. 1995; 268(2 Pt 1):G328-38. DOI: 10.1152/ajpgi.1995.268.2.G328. View

15.

Van Laethem J, Marchant A, Delvaux A, Goldman M, Robberecht P, Velu T . Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology. 1995; 108(6):1917-22. DOI: 10.1016/0016-5085(95)90158-2. View

16.

Norman J, Franz M, Messina J, Riker A, Fabri P, Rosemurgy A . Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery. 1995; 117(6):648-55. DOI: 10.1016/s0039-6060(95)80008-5. View

17.

Norman J, Franz M, Fink G, Messina J, Fabri P, Gower W . Decreased mortality of severe acute pancreatitis after proximal cytokine blockade. Ann Surg. 1995; 221(6):625-31; discussion 631-4. PMC: 1234684. DOI: 10.1097/00000658-199506000-00002. View

18.

Krakauer T . IL-10 inhibits the adhesion of leukocytic cells to IL-1-activated human endothelial cells. Immunol Lett. 1995; 45(1-2):61-5. DOI: 10.1016/0165-2478(94)00226-h. View

19.

Norman J, Fink G, Franz M . Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression. Arch Surg. 1995; 130(9):966-70. DOI: 10.1001/archsurg.1995.01430090052018. View

20.

van der Poll T, Marchant A, Buurman W, Berman L, Keogh C, Lazarus D . Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol. 1995; 155(11):5397-401. View